In the 12 days leading up to our holiday hiatus, we are looking back on the past year and sharing some highlights in Massachusetts General Hospital research news from each month of 2017.
Blog
Massachusetts General Hospital recently established four endowed chairs. Meet the investigators whose work and contributions have been recognized through their appointment to these roles and please join us in congratulating them!
Huntington’s disease (HD) is a fatal genetic disorder that causes the progressive breakdown of nerve cells in the brain.
Researchers from MIT and Mass General recently unveiled a wireless, portable system for monitoring individuals during sleep that could provide new insights into sleep disorders and reduce the need for time and cost-intensive overnight sleep studies in a clinical sleep lab.
n a recent study published in the Journal of the American Society of Nephrology, Massachusetts General Hospital researchers share new findings about the link between loss of appetite and loss of smell in these patients.
We are proud to announce that Massachusetts General Hospital has once again been named among America’s Top Hospitals, earning the number four spot on the honor roll of best hospitals.
At Massachusetts General Hospital, a real-life Trojan horse scenario that takes place on the nanoscale level could provide a way to sneak cancer drugs into fortified tumor cells so the drugs can attack from within.
They say that eyes are the windows to the soul, but for individuals with autism, a lack of eye contact can reveal much more. A team of investigators based at the Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital has shed light on why those with autism often avoid looking others in the eyes.
Every year, Massachusetts General Hospital celebrates Research Staff Appreciation Day to recognize and thank the research staff members who provide direct scientific support to faculty investigators across the Mass General research enterprise.